CoverageForm 410-K10-Q8-K13D13G13F

TALK · Talkspace, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · TALK

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$61.68M-$59.38M$54.31M$52.18M-$47.40M$46.06M$45.42M-
Cost of Revenue----$28.90M-$25.78M$25.11M$23.68M-
Gross Profit----$23.28M-$21.62M$20.95M$21.73M-
R&D$2.66M-$1.78M$2.56M$3.32M-$2.35M$2.16M$3.74M-
SG&A$12.82M-$5.09M$5.73M$5.21M-$5.16M$7.34M$5.20M-
Total Operating Expenses$68.81M-$57.18M$56.10M$24.37M-$21.52M$24.44M$23.41M-
D&A$1.54M-$231.0K$220.0K$666.0K---$201.0K-
Operating Income($7.13M)-$2.20M($1.79M)($1.08M)-$99.0K($3.49M)$1.68M-
Interest Expense----------
Income Tax$124.0K-$25.0K$76.0K$123.0K-($74.0K)$32.0K$165.0K-
Net Income($6.31M)-$3.25M($541.0K)$318.0K-$1.87M($474.0K)($1.47M)-
EPS - Basic($0.04)-$0.02-$0.00-$0.01$0.00($0.01)-
EPS - Diluted($0.04)-$0.02-$0.00-$0.01$0.00($0.01)-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$31.41M$37.35M$39.51M$54.34M$60.08M$76.69M$118.99M$114.91M$120.28M$123.91M
Accounts Receivable$23.59M$16.06M$14.93M$15.42M$13.25M$9.64M$9.60M$11.55M$11.04M$10.17M
Inventory----------
Accounts Payable$11.65M$8.50M$9.62M$8.62M$10.53M$7.71M$8.30M$7.73M$5.80M$6.11M
Current Assets$110.50M$111.06M$114.48M$120.67M$124.12M$130.18M$131.52M$128.77M$135.73M$139.80M
Total Assets$136.19M$134.86M$129.06M$132.79M$134.25M$138.68M$138.23M$133.79M$138.28M$142.22M
Current Liabilities$22.81M$17.40M$19.38M$18.54M$19.12M$19.02M$19.05M$17.78M$15.69M$21.65M
Long-term Debt----------
Total Liabilities$23.14M$17.85M$19.95M$19.84M$20.83M$21.28M$20.64M$19.75M$18.70M$23.57M
Stockholders' Equity$113.06M$117.02M$109.11M$112.94M$113.42M$117.39M$117.59M$114.04M$119.58M$118.65M
Retained Earnings($267.75M)($261.44M)($266.21M)($269.46M)($268.92M)($269.24M)($270.45M)($272.32M)($271.85M)($270.38M)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow($4.42M)---($1.24M)---($3.39M)-
Investing Cash Flow($793.0K)---($9.02M)---($385.0K)-
Financing Cash Flow($730.0K)---($6.36M)---$146.0K-
CapEx--------$385.0K-
Free Cash Flow--------($3.78M)-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin----44.6%-45.6%45.5%47.8%-
Operating margin-11.6%-3.7%-3.3%-2.1%-0.2%-7.6%3.7%-
EBITDA margin-9.1%-4.1%-2.9%-0.8%---4.1%-
Net margin-10.2%-5.5%-1.0%0.6%-4.0%-1.0%-3.2%-
Free cash flow margin---------8.3%-
FCF / Net income--------2.58-
R&D / Revenue4.3%-3.0%4.7%6.4%-5.0%4.7%8.2%-
SG&A / Revenue20.8%-8.6%10.5%10.0%-10.9%15.9%11.4%-
Effective tax rate--0.8%-27.9%--4.1%---
Return on assets-4.6%-2.5%-0.4%0.2%-1.4%-0.4%-1.1%-
Return on equity-5.6%-3.0%-0.5%0.3%-1.6%-0.4%-1.2%-
Return on invested capital----------
Liquidity
Current ratio4.846.385.916.516.496.846.907.248.656.46
Quick ratio4.846.385.916.516.496.846.907.248.656.46
Cash ratio1.382.152.042.933.144.036.256.467.675.72
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier1.201.151.181.181.181.181.181.171.161.20
Liabilities / Assets0.170.130.150.150.160.150.150.150.140.17
Efficiency
Asset turnover0.45-0.460.410.39-0.340.340.33-
Inventory turnover----------
Days sales outstanding140d-92d104d93d-74d92d89d-
Days inventory outstanding----------
Days payable outstanding----133d-118d112d89d-
Cash conversion cycle----------
Valuation
P / E--138.0x---209.0x---
P / B7.6x-4.3x4.1x4.0x-3.1x3.4x5.0x-
P / S14.0x-8.0x8.6x8.6x-7.7x8.4x13.3x-
EV / EBITDA--178.6x-----256.7x-
Growth
Revenue growth (YoY)18.2%-25.3%17.9%14.9%-22.6%29.2%36.2%-
Revenue CAGR (3y)22.8%-26.5%22.1%24.3%-21.6%37.1%--
Revenue CAGR (5y)----------
Gross profit growth (YoY)----7.1%-14.7%17.6%29.8%-
Operating income growth (YoY)-556.9%-2120.2%48.7%---98.1%--81.4%-
Net income growth (YoY)--73.5%-14.1%---89.9%83.3%-
EPS growth (YoY)--100.0%-----92.3%-
EPS CAGR (3y)------0.0%---
EPS CAGR (5y)----------
FCF growth (YoY)--------73.1%-
FCF CAGR (5y)----------
Book value growth (YoY)-0.3%-0.3%-7.2%-1.0%-5.2%-1.1%-0.1%-4.8%-1.7%-7.0%

Peer comparison

Same SIC group: Services-Health Services

CompanyRevenue (last FY)Net marginROE
WGS$427.54M-4.9%-6.8%
BLDE$197.14M21.0%14.8%
PRVA--3.1%
LFST$1.42B0.7%0.6%
SHCR---

Comparing Talkspace against the 5 most active filers in the same SIC group.